Michael Wilson
Concepts (270)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Emergency Service, Hospital | 56 | 2023 | 488 | 10.000 |
Why?
| Mental Disorders | 18 | 2023 | 389 | 6.220 |
Why?
| Psychomotor Agitation | 18 | 2022 | 51 | 6.080 |
Why?
| Antipsychotic Agents | 16 | 2022 | 232 | 5.000 |
Why?
| Emergency Medicine | 9 | 2022 | 52 | 2.880 |
Why?
| Benzodiazepines | 12 | 2017 | 70 | 2.780 |
Why?
| Mass Screening | 9 | 2023 | 351 | 2.630 |
Why?
| Emergency Services, Psychiatric | 6 | 2020 | 13 | 2.160 |
Why?
| Haloperidol | 6 | 2022 | 46 | 2.100 |
Why?
| Risk Assessment | 9 | 2020 | 1262 | 1.950 |
Why?
| Alcoholic Intoxication | 7 | 2017 | 19 | 1.920 |
Why?
| Emergencies | 5 | 2022 | 87 | 1.420 |
Why?
| Risperidone | 3 | 2017 | 25 | 1.320 |
Why?
| Mental Health | 2 | 2023 | 216 | 1.300 |
Why?
| Humans | 75 | 2023 | 49827 | 1.270 |
Why?
| Suicidal Ideation | 4 | 2022 | 96 | 1.180 |
Why?
| Opioid-Related Disorders | 3 | 2021 | 375 | 1.130 |
Why?
| Psychotic Disorders | 2 | 2019 | 133 | 1.110 |
Why?
| Vital Signs | 2 | 2017 | 18 | 1.060 |
Why?
| Adult | 30 | 2021 | 13160 | 1.050 |
Why?
| Consensus | 5 | 2021 | 143 | 1.000 |
Why?
| Delirium | 4 | 2019 | 47 | 0.880 |
Why?
| Practice Guidelines as Topic | 5 | 2021 | 448 | 0.860 |
Why?
| Male | 35 | 2021 | 25093 | 0.820 |
Why?
| Substance-Related Disorders | 5 | 2020 | 595 | 0.790 |
Why?
| Thiazoles | 3 | 2022 | 51 | 0.770 |
Why?
| Thyroid Crisis | 2 | 2017 | 6 | 0.740 |
Why?
| Female | 32 | 2021 | 26329 | 0.740 |
Why?
| Hepatitis C, Chronic | 2 | 2013 | 82 | 0.740 |
Why?
| Piperazines | 3 | 2022 | 117 | 0.720 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2020 | 553 | 0.710 |
Why?
| Guideline Adherence | 1 | 2021 | 132 | 0.710 |
Why?
| Middle Aged | 21 | 2019 | 11997 | 0.690 |
Why?
| Nurses | 1 | 2020 | 48 | 0.680 |
Why?
| Prescription Drug Misuse | 1 | 2019 | 31 | 0.660 |
Why?
| Drug Monitoring | 1 | 2019 | 77 | 0.660 |
Why?
| Droperidol | 2 | 2015 | 6 | 0.660 |
Why?
| Drug Therapy, Combination | 7 | 2017 | 378 | 0.650 |
Why?
| Preventive Health Services | 1 | 2019 | 51 | 0.650 |
Why?
| Geriatrics | 1 | 2019 | 46 | 0.640 |
Why?
| Retrospective Studies | 15 | 2022 | 6117 | 0.630 |
Why?
| Diagnosis, Differential | 9 | 2019 | 1036 | 0.630 |
Why?
| Schizophrenia | 2 | 2019 | 256 | 0.620 |
Why?
| Informed Consent | 1 | 2019 | 96 | 0.620 |
Why?
| Pain Management | 1 | 2019 | 146 | 0.610 |
Why?
| Anesthetics, Dissociative | 2 | 2015 | 15 | 0.610 |
Why?
| Aggression | 2 | 2015 | 49 | 0.600 |
Why?
| Patient Selection | 1 | 2019 | 251 | 0.590 |
Why?
| Substance Abuse Detection | 1 | 2017 | 92 | 0.580 |
Why?
| Physicians | 2 | 2020 | 234 | 0.580 |
Why?
| Oxygen | 4 | 2013 | 325 | 0.580 |
Why?
| Pheochromocytoma | 1 | 2017 | 35 | 0.580 |
Why?
| Psychological Tests | 1 | 2017 | 50 | 0.580 |
Why?
| Analgesics, Opioid | 2 | 2019 | 532 | 0.580 |
Why?
| Medical History Taking | 1 | 2017 | 47 | 0.580 |
Why?
| Age Factors | 2 | 2017 | 1090 | 0.570 |
Why?
| Hypotension | 1 | 2017 | 63 | 0.560 |
Why?
| Attitude of Health Personnel | 1 | 2020 | 348 | 0.560 |
Why?
| Psychiatric Status Rating Scales | 1 | 2018 | 319 | 0.560 |
Why?
| Patient Acceptance of Health Care | 1 | 2020 | 327 | 0.560 |
Why?
| Physical Examination | 1 | 2017 | 90 | 0.560 |
Why?
| Neuroleptic Malignant Syndrome | 1 | 2016 | 4 | 0.560 |
Why?
| Steroids | 1 | 2016 | 57 | 0.550 |
Why?
| Administration, Oral | 5 | 2017 | 423 | 0.540 |
Why?
| Databases, Factual | 1 | 2019 | 664 | 0.530 |
Why?
| Serotonin Syndrome | 1 | 2015 | 6 | 0.530 |
Why?
| Ketamine | 2 | 2017 | 60 | 0.520 |
Why?
| Injections, Intramuscular | 5 | 2020 | 54 | 0.520 |
Why?
| Cocaine-Related Disorders | 1 | 2017 | 205 | 0.510 |
Why?
| Disease Management | 2 | 2016 | 174 | 0.500 |
Why?
| Length of Stay | 2 | 2015 | 623 | 0.480 |
Why?
| Pain, Referred | 1 | 2014 | 1 | 0.470 |
Why?
| Toothache | 1 | 2014 | 2 | 0.470 |
Why?
| Alcoholism | 2 | 2016 | 232 | 0.470 |
Why?
| Depressive Disorder | 3 | 2013 | 339 | 0.470 |
Why?
| Facial Pain | 1 | 2014 | 10 | 0.470 |
Why?
| Hepatitis B, Chronic | 1 | 2013 | 16 | 0.450 |
Why?
| Substance Withdrawal Syndrome | 3 | 2021 | 168 | 0.440 |
Why?
| Fasciitis, Necrotizing | 1 | 2012 | 7 | 0.440 |
Why?
| Suicide | 3 | 2019 | 74 | 0.440 |
Why?
| Acute Disease | 5 | 2017 | 369 | 0.440 |
Why?
| Confined Spaces | 1 | 2012 | 4 | 0.410 |
Why?
| Firefighters | 1 | 2012 | 4 | 0.410 |
Why?
| United States | 9 | 2023 | 4838 | 0.400 |
Why?
| Blood Pressure | 4 | 2017 | 514 | 0.390 |
Why?
| Safety | 1 | 2012 | 78 | 0.390 |
Why?
| Pilot Projects | 4 | 2022 | 699 | 0.390 |
Why?
| Pregnancy Complications | 1 | 2015 | 382 | 0.380 |
Why?
| Prospective Studies | 5 | 2019 | 2344 | 0.360 |
Why?
| Myocardial Infarction | 1 | 2014 | 382 | 0.350 |
Why?
| Aged | 9 | 2019 | 9272 | 0.350 |
Why?
| Social Adjustment | 1 | 2010 | 29 | 0.350 |
Why?
| Heart Rate | 3 | 2017 | 292 | 0.340 |
Why?
| HIV Infections | 1 | 2013 | 354 | 0.340 |
Why?
| Geriatric Assessment | 2 | 2019 | 112 | 0.320 |
Why?
| Delivery of Health Care | 5 | 2023 | 307 | 0.320 |
Why?
| Anxiety | 3 | 2020 | 269 | 0.310 |
Why?
| Social Support | 1 | 2010 | 265 | 0.310 |
Why?
| Pandemics | 3 | 2021 | 554 | 0.300 |
Why?
| Liver Cirrhosis | 1 | 2010 | 218 | 0.300 |
Why?
| Sweating | 2 | 2017 | 7 | 0.290 |
Why?
| Advisory Committees | 2 | 2017 | 63 | 0.280 |
Why?
| Publishing | 1 | 2007 | 39 | 0.280 |
Why?
| Drug Interactions | 3 | 2012 | 206 | 0.280 |
Why?
| Young Adult | 7 | 2021 | 3936 | 0.280 |
Why?
| Periodicals as Topic | 1 | 2007 | 58 | 0.280 |
Why?
| Emergency Medical Services | 2 | 2022 | 111 | 0.280 |
Why?
| Predictive Value of Tests | 2 | 2019 | 904 | 0.260 |
Why?
| Patient Discharge | 3 | 2023 | 322 | 0.260 |
Why?
| Restraint, Physical | 2 | 2022 | 20 | 0.250 |
Why?
| California | 3 | 2019 | 87 | 0.250 |
Why?
| Oxytocin | 2 | 2013 | 19 | 0.230 |
Why?
| Risk Factors | 6 | 2017 | 3619 | 0.220 |
Why?
| Fever | 2 | 2016 | 117 | 0.220 |
Why?
| Feasibility Studies | 2 | 2022 | 374 | 0.220 |
Why?
| Psychotherapy | 2 | 2013 | 104 | 0.210 |
Why?
| Antidepressive Agents | 2 | 2013 | 176 | 0.200 |
Why?
| Aftercare | 2 | 2023 | 76 | 0.200 |
Why?
| Dextroamphetamine | 1 | 2021 | 39 | 0.200 |
Why?
| Referral and Consultation | 2 | 2021 | 287 | 0.190 |
Why?
| Antidepressive Agents, Second-Generation | 2 | 2017 | 26 | 0.190 |
Why?
| Controlled Clinical Trials as Topic | 1 | 2020 | 21 | 0.180 |
Why?
| Amphetamine-Related Disorders | 1 | 2021 | 94 | 0.180 |
Why?
| Akathisia, Drug-Induced | 1 | 2020 | 12 | 0.180 |
Why?
| Narcotic Antagonists | 1 | 2021 | 130 | 0.180 |
Why?
| Emergency Nursing | 1 | 2020 | 7 | 0.180 |
Why?
| Crisis Intervention | 1 | 2020 | 10 | 0.180 |
Why?
| Myocardial Ischemia | 1 | 2021 | 120 | 0.180 |
Why?
| Death, Sudden | 1 | 2019 | 10 | 0.170 |
Why?
| Buprenorphine | 1 | 2021 | 134 | 0.170 |
Why?
| Analysis of Variance | 2 | 2011 | 565 | 0.170 |
Why?
| Meningoencephalitis | 1 | 2019 | 6 | 0.170 |
Why?
| Methamphetamine | 1 | 2021 | 200 | 0.170 |
Why?
| Meningitis, Cryptococcal | 1 | 2019 | 10 | 0.170 |
Why?
| Loxapine | 1 | 2019 | 2 | 0.170 |
Why?
| Lorazepam | 1 | 2019 | 12 | 0.170 |
Why?
| Central Nervous System Stimulants | 1 | 2021 | 213 | 0.160 |
Why?
| Ethanol | 2 | 2013 | 338 | 0.160 |
Why?
| Ethics, Research | 1 | 2019 | 39 | 0.160 |
Why?
| Child | 5 | 2019 | 6824 | 0.160 |
Why?
| Hypercalcemia | 1 | 2018 | 33 | 0.160 |
Why?
| Ambulatory Care Facilities | 1 | 2019 | 125 | 0.160 |
Why?
| Hypnotics and Sedatives | 3 | 2017 | 75 | 0.160 |
Why?
| Hospitals, University | 2 | 2018 | 77 | 0.160 |
Why?
| Stress, Physiological | 1 | 2019 | 170 | 0.160 |
Why?
| Health Services Research | 1 | 2019 | 150 | 0.150 |
Why?
| Prisoners | 1 | 2019 | 87 | 0.150 |
Why?
| Qualitative Research | 1 | 2020 | 325 | 0.150 |
Why?
| Respiratory Rate | 1 | 2017 | 7 | 0.150 |
Why?
| Psychiatry | 1 | 2019 | 105 | 0.150 |
Why?
| Comorbidity | 2 | 2017 | 618 | 0.150 |
Why?
| Goals | 1 | 2017 | 40 | 0.150 |
Why?
| Headache | 1 | 2017 | 76 | 0.150 |
Why?
| Adrenal Gland Neoplasms | 1 | 2017 | 51 | 0.140 |
Why?
| Physician-Patient Relations | 1 | 2018 | 140 | 0.140 |
Why?
| Bipolar Disorder | 1 | 2019 | 192 | 0.140 |
Why?
| Pneumonia, Viral | 1 | 2020 | 168 | 0.140 |
Why?
| Korsakoff Syndrome | 1 | 2016 | 1 | 0.140 |
Why?
| Patient Satisfaction | 1 | 2018 | 273 | 0.140 |
Why?
| Veterans | 1 | 2023 | 550 | 0.140 |
Why?
| Coronavirus Infections | 1 | 2020 | 178 | 0.140 |
Why?
| Vitamin B Complex | 1 | 2016 | 18 | 0.140 |
Why?
| Muscle Rigidity | 1 | 2016 | 1 | 0.140 |
Why?
| Thiamine | 1 | 2016 | 17 | 0.140 |
Why?
| Regression Analysis | 1 | 2017 | 395 | 0.140 |
Why?
| Chronic Pain | 1 | 2019 | 161 | 0.140 |
Why?
| Communication | 1 | 2018 | 244 | 0.140 |
Why?
| Catatonia | 1 | 2016 | 8 | 0.140 |
Why?
| Health Policy | 1 | 2017 | 153 | 0.130 |
Why?
| Polypharmacy | 1 | 2015 | 14 | 0.130 |
Why?
| Suicide, Attempted | 2 | 2022 | 76 | 0.130 |
Why?
| Retreatment | 1 | 2015 | 58 | 0.130 |
Why?
| Anti-Inflammatory Agents | 1 | 2016 | 162 | 0.130 |
Why?
| Chronic Disease | 1 | 2017 | 563 | 0.120 |
Why?
| Dibenzothiazepines | 1 | 2014 | 10 | 0.120 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 130 | 0.120 |
Why?
| Jaw | 1 | 2014 | 4 | 0.120 |
Why?
| Adolescent | 4 | 2019 | 6340 | 0.120 |
Why?
| Aged, 80 and over | 2 | 2019 | 3125 | 0.110 |
Why?
| Diagnosis, Dual (Psychiatry) | 1 | 2013 | 41 | 0.110 |
Why?
| Quinolones | 1 | 2014 | 39 | 0.110 |
Why?
| Drug Prescriptions | 1 | 2014 | 95 | 0.110 |
Why?
| Cohort Studies | 1 | 2017 | 1422 | 0.110 |
Why?
| Hand Disinfection | 1 | 2013 | 7 | 0.110 |
Why?
| Breath Tests | 1 | 2013 | 39 | 0.110 |
Why?
| Drug Overdose | 1 | 2015 | 158 | 0.110 |
Why?
| Leukocyte Count | 1 | 2012 | 70 | 0.110 |
Why?
| Sodium | 1 | 2012 | 92 | 0.110 |
Why?
| Creatinine | 1 | 2012 | 140 | 0.110 |
Why?
| Sex Factors | 1 | 2015 | 693 | 0.100 |
Why?
| Hemoglobins | 1 | 2012 | 108 | 0.100 |
Why?
| Lactic Acid | 1 | 2012 | 76 | 0.100 |
Why?
| Forensic Psychiatry | 1 | 2012 | 6 | 0.100 |
Why?
| United States Occupational Safety and Health Administration | 1 | 2012 | 5 | 0.100 |
Why?
| Sodium Bicarbonate | 1 | 2012 | 9 | 0.100 |
Why?
| Hazardous Substances | 1 | 2012 | 15 | 0.100 |
Why?
| C-Reactive Protein | 1 | 2012 | 142 | 0.100 |
Why?
| Acidosis | 1 | 2012 | 40 | 0.100 |
Why?
| Hypothermia, Induced | 1 | 2012 | 39 | 0.100 |
Why?
| Fluid Therapy | 1 | 2012 | 79 | 0.100 |
Why?
| Occupational Health | 1 | 2012 | 67 | 0.100 |
Why?
| Anti-Dyskinesia Agents | 1 | 2010 | 1 | 0.090 |
Why?
| Blood Glucose | 1 | 2012 | 432 | 0.090 |
Why?
| Sick Role | 1 | 2010 | 14 | 0.090 |
Why?
| Behavior Therapy | 1 | 2012 | 181 | 0.090 |
Why?
| Personality Inventory | 1 | 2010 | 49 | 0.090 |
Why?
| Alcohol-Related Disorders | 1 | 2010 | 44 | 0.090 |
Why?
| Liver Function Tests | 1 | 2010 | 46 | 0.090 |
Why?
| Interferons | 1 | 2010 | 40 | 0.090 |
Why?
| Religion and Psychology | 1 | 2010 | 27 | 0.090 |
Why?
| Viral Load | 1 | 2010 | 76 | 0.090 |
Why?
| Clinical Trials as Topic | 1 | 2012 | 460 | 0.090 |
Why?
| Social Environment | 1 | 2010 | 80 | 0.080 |
Why?
| Cross-Sectional Studies | 2 | 2014 | 1541 | 0.080 |
Why?
| Psychometrics | 1 | 2010 | 220 | 0.080 |
Why?
| Transportation of Patients | 1 | 2008 | 37 | 0.080 |
Why?
| Antiviral Agents | 1 | 2010 | 174 | 0.080 |
Why?
| Pregnancy | 1 | 2015 | 2584 | 0.080 |
Why?
| Time Factors | 2 | 2012 | 2912 | 0.080 |
Why?
| Tomography, X-Ray Computed | 1 | 2012 | 1159 | 0.070 |
Why?
| National Institutes of Health (U.S.) | 1 | 2007 | 46 | 0.070 |
Why?
| Research Support as Topic | 1 | 2007 | 46 | 0.070 |
Why?
| Genetic Predisposition to Disease | 1 | 2010 | 510 | 0.070 |
Why?
| Hydrocortisone | 2 | 2019 | 107 | 0.070 |
Why?
| Double-Blind Method | 2 | 2021 | 674 | 0.070 |
Why?
| Evidence-Based Medicine | 2 | 2017 | 248 | 0.070 |
Why?
| Quality of Life | 1 | 2010 | 833 | 0.060 |
Why?
| Stroke | 1 | 2008 | 492 | 0.050 |
Why?
| United States Department of Veterans Affairs | 1 | 2023 | 279 | 0.050 |
Why?
| Quality of Health Care | 1 | 2023 | 185 | 0.050 |
Why?
| Dynorphins | 1 | 2019 | 4 | 0.040 |
Why?
| Police | 1 | 2019 | 4 | 0.040 |
Why?
| Glycopeptides | 1 | 2019 | 10 | 0.040 |
Why?
| Sampling Studies | 1 | 2019 | 37 | 0.040 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2019 | 74 | 0.040 |
Why?
| Diuretics, Osmotic | 1 | 2019 | 4 | 0.040 |
Why?
| Mannitol | 1 | 2019 | 14 | 0.040 |
Why?
| Consciousness Disorders | 1 | 2019 | 7 | 0.040 |
Why?
| Intracranial Hypertension | 1 | 2019 | 31 | 0.040 |
Why?
| Cryptococcus neoformans | 1 | 2019 | 27 | 0.040 |
Why?
| Guidelines as Topic | 1 | 2019 | 111 | 0.040 |
Why?
| Education | 1 | 2019 | 41 | 0.040 |
Why?
| Norepinephrine | 1 | 2019 | 107 | 0.040 |
Why?
| Text Messaging | 1 | 2018 | 18 | 0.040 |
Why?
| Telephone | 1 | 2018 | 70 | 0.040 |
Why?
| Conscious Sedation | 1 | 2017 | 24 | 0.040 |
Why?
| Dementia | 1 | 2019 | 141 | 0.040 |
Why?
| Health Personnel | 1 | 2020 | 241 | 0.040 |
Why?
| Emergency Treatment | 1 | 2017 | 31 | 0.040 |
Why?
| Excitatory Amino Acid Antagonists | 1 | 2017 | 50 | 0.040 |
Why?
| Flumazenil | 1 | 2016 | 4 | 0.040 |
Why?
| Psychoses, Substance-Induced | 1 | 2016 | 9 | 0.040 |
Why?
| Phenobarbital | 1 | 2016 | 17 | 0.040 |
Why?
| Delusions | 1 | 2016 | 9 | 0.030 |
Why?
| Patient Readmission | 1 | 2018 | 222 | 0.030 |
Why?
| Case-Control Studies | 1 | 2019 | 1128 | 0.030 |
Why?
| Mental Health Services | 1 | 2017 | 194 | 0.030 |
Why?
| Hospital Charges | 1 | 2014 | 43 | 0.030 |
Why?
| Theory of Mind | 1 | 2013 | 1 | 0.030 |
Why?
| Interview, Psychological | 1 | 2013 | 23 | 0.030 |
Why?
| Phobic Disorders | 1 | 2013 | 15 | 0.030 |
Why?
| Behavior | 1 | 2013 | 45 | 0.030 |
Why?
| Saliva | 1 | 2013 | 54 | 0.030 |
Why?
| False Positive Reactions | 1 | 2013 | 63 | 0.030 |
Why?
| Social Behavior | 1 | 2013 | 72 | 0.030 |
Why?
| Affect | 1 | 2013 | 99 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2014 | 673 | 0.030 |
Why?
| Neuropsychological Tests | 1 | 2013 | 351 | 0.020 |
Why?
| Cognition | 1 | 2013 | 336 | 0.020 |
Why?
| Child, Preschool | 1 | 2014 | 3853 | 0.020 |
Why?
|
|
Wilson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|